GAM Systematic’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$638K Buy
12,196
+1,883
+18% +$105K 0.09% 371
2017
Q2
$603K Sell
10,313
-7,902
-43% -$411K 0.09% 382
2017
Q1
$835K Buy
18,215
+4,829
+36% +$240K 0.16% 237
2016
Q4
$704K Buy
13,386
+2,608
+24% +$126K 0.17% 253
2016
Q3
$480K Sell
10,778
-8,910
-45% -$386K 0.1% 382
2016
Q2
$751K Buy
19,688
+10,877
+123% +$478K 0.18% 229
2016
Q1
$363K Sell
8,811
-2,799
-24% -$115K 0.1% 370
2015
Q4
$563K Buy
11,610
+2,065
+22% +$91.9K 0.16% 265
2015
Q3
$382K Buy
+9,545
New +$417K 0.09% 411

Other funds holding SYNH

GAM Systematic's SYNH Position: Q3 2017 in Review

GAM Systematic increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 18% in Q3 2017, buying an estimated $105K and bringing the position to 12,196 shares worth $638K. The position accounts for 0.09% of the portfolio, ranked #371.

GAM Systematic first reported a position in SYNH in Q3 2015 and has held it in 9 quarters since. The position peaked at $835K in Q1 2017. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • GAM Systematic held 12,196 shares of Syneos Health, Inc. Class A Common Stock worth $638K as of Q3 2017.
  • GAM Systematic bought 1,883 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $105K.
  • Syneos Health, Inc. Class A Common Stock made up 0.09% of GAM Systematic's portfolio in Q3 2017, its #371 holding.
  • GAM Systematic first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and has held it in 9 quarters since.
  • GAM Systematic's Syneos Health, Inc. Class A Common Stock position peaked at $835K in Q1 2017.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.